Displaying items by tag: department of neurosurgery

Neuroengineering blends engineering principles with neuroscience to find better ways to treat neurological conditions and to build on understanding how the brain and nervous system function.
UAB pediatric neurosurgeon Jeffrey Blount co-founded the group who presented the resolution on fortification of folic acid in staple foods to the WHO.
UAB Neurosurgery heads to local elementary schools to encourage young students to consider the STEM fields as they ponder career choices.
UAB’s newest members of the prestigious National Academy of Medicine were selected for their outstanding professional achievements and exceptional commitment to service.
The study will examine a protein that may help slow bleeding in the brain when given within a two-hour window following the first signs of hemorrhage.
The new technique to predict seizure clusters could, if confirmed, have a profound impact on patients with drug-resistant epilepsy who are prone to seizure clusters. 
An aneurysm is a bulge in a blood vessel caused by a weakness in the blood vessel wall, resulting in an increase of pressure in a small area and causing the vessel to balloon.
For one UAB employee, having a nephew compete in The World Games makes Birmingham’s and UAB’s support of the games come full circle.
Medical professionals are calling on the World Health Assembly to pass a resolution calling for folic acid fortification in staple foods to prevent spina bifida worldwide.
Radiofrequency ablation precisely delivers heat energy that can destroy lesions within the brain that are the cause of seizures.
The fields of neuroengineering and brain-computer interfaces could have a tremendous impact on a number of neurologic conditions, such as stroke, neurodegenerative disorders, Parkinson’s disease, dementia and other brain diseases.
The grant will fund research surrounding next-generation human models that could potentially aid in the development of treatment for glioblastoma.
UAB’s new intraoperative MRI suite allows for real time magnetic resonance imaging during surgical procedures.

At UAB, the company IN8bio Inc. is running a Phase I clinical trial to treat glioblastoma multiforme, the most aggressive type of cancer that originates in the brain.

Page 1 of 4